Sabitlenmiş Tweet
Samya Al mazroei, MD,FRCPC
10.7K posts

Samya Al mazroei, MD,FRCPC
@samya_saif
Consultant Emergency Medicine and Neuro Critical Care. Oman
Oman Katılım Nisan 2015
278 Takip Edilen83 Takipçiler
Samya Al mazroei, MD,FRCPC retweetledi

Been reviewing post-arrest seizures and prognosis.
Just took another look at this paper. TTM2 substudy in Neurology 2025 looking at determinants of good outcome after postanoxic status epilepticus.
#NeuroCritCare #Neuroprognostication

English
Samya Al mazroei, MD,FRCPC retweetledi

مختبرات بن عُميرة، مختبر صحي بإدارة عمانية تطمح لتقديم خدمات صحية مميزة لعملائها.
#براند_عماني يستحق الأولوية في الدعم تماشيا مع دعم الحكومة للمحتوى المحلّي.
مُختبرات بنْ عُميرة@bin_omaira_labs
عملاؤنا الأعزاء، يسرنا أن نعلن عن تدشين الموقع الرسمي لمختبرات بنْ عُميرة – المختبر المرجعي العُماني الأقرب لكم. تصفحوا خدماتنا بالعربية والإنجليزية، واطّلعوا على قائمة الفحوصات والأسعار بكل شفافية. 🌐 Bin-omaira.com نفتخر بخدمتكم لرفع مستوى صحة المجتمع.
العربية
Samya Al mazroei, MD,FRCPC retweetledi
Samya Al mazroei, MD,FRCPC retweetledi

{فَأَوْجَسَ فِي نَفْسِهِ خِيفَةً} أوجس في نفسه خوفًا،
لم ينطق به، ولم يُصَغْه في دعاء، ولم يتضرَّع به إلى ربه، بل بقي في صدره، ورجفةً لا يعلمها إلا الله.
فجاءه الرد الإلهي مباشرة،
قبل أن يتكلم، قبل أن يبكي، قبل أن يرفع يديه:
{قُلْنَا لَا تَخَفْ إِنَّكَ أَنْتَ الْأَعْلَى}
اللهم، إنَّا نرفع إليك كل مخاوفنا التي لا نستطيع صياغتها في كلمات، أنت تعلمها قبل أن نعلمها، وتسمعها قبل أن تنطق بها ألسنتنا.
العربية
Samya Al mazroei, MD,FRCPC retweetledi
Samya Al mazroei, MD,FRCPC retweetledi

If you missed this, read it before the HI-PEITHO trial comes out on 3/28
I think the STRATIFY trial will be integral to understanding and applying the results of the HI-PEITHO trial 😁🤞
𝙟𝙤𝙨𝙝 𝙛𝙖𝙧𝙠𝙖𝙨 💊@PulmCrit
Fresh blog: STRATIFY trial for PE Peripheral tPA infusion is EQUALLY EFFECTIVE as compared to ultrasound-assisted thrombolysis Catheter-directed thrombolysis for PE is dead We can get the same benefits with peripheral tPA infusions (w/o procedural costs & complications)...#1/2
English
Samya Al mazroei, MD,FRCPC retweetledi

When the senior Omani mediator speaks, the smart set should listen: economist.com/by-invitation/…
English
Samya Al mazroei, MD,FRCPC retweetledi
Samya Al mazroei, MD,FRCPC retweetledi
Samya Al mazroei, MD,FRCPC retweetledi
Samya Al mazroei, MD,FRCPC retweetledi
Samya Al mazroei, MD,FRCPC retweetledi
Samya Al mazroei, MD,FRCPC retweetledi

Just read an interesting paper, "Long-term outcomes of poor-grade aneurysmal subarachnoid hemorrhage"
New multicenter data (n=1,589) just published in the Journal of Neurosurgery looked at long-term outcomes in poor-grade aSAH. The headline finding was 51% long-term mortality.
What I found more interesting, among patients who received EVD before aneurysm treatment, 39% showed clinical improvement (GCS increase) after drainage.

English
Samya Al mazroei, MD,FRCPC retweetledi

The practical guide to the updated seizure classification 2025 comprehensively explains how to approach seizure classification using the patient’s semiology and complementary tests. Learn clearly with the cited case videos - case : S10 doi.org/10.1002/epd2.7… @SBeniczky

English
Samya Al mazroei, MD,FRCPC retweetledi

Get ready for this. These Chinese investigators report a cohort of 121 malignant MCA infarction patients age >60, 47 of whom underwent drill-assisted sterotactic aspiration of the infarcted tissue from 24-72 hrs after onset. Check out the CT images and the 70 mL of nectrotic brain tissue in the image below to give you an idera of what they were doing.
Retrospective, not randomized -- but the results were great.
Herniation: 47% vs 9%
Death: 65% vs 9%
Favorable mRS (0-3): 3% vs 26%
Not only #curingcoma –– cheating death.
pmc.ncbi.nlm.nih.gov/articles/PMC12…

English
Samya Al mazroei, MD,FRCPC retweetledi
Samya Al mazroei, MD,FRCPC retweetledi
Samya Al mazroei, MD,FRCPC retweetledi
Samya Al mazroei, MD,FRCPC retweetledi

💊Low-dose rivaroxaban + antiplatelet therapy for symptomatic intracranial atherosclerotic stenosis
Dual pathway inhibition may be associated with ⬇️ lower risk of recurrent stroke compared to antiplatelet therapy alone
Read more here!👇
journals.sagepub.com/doi/abs/10.117…

English

















